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Abstract: The in vivo imaging of mice makes it possible to analyze disease progress non-invasively 
through reporter gene expression. As the removal of hair improves the accuracy of in vivo imaging, 
gene-modified mice with a reporter gene are often crossed with Hos:HR-1 mutant mice homozygous 
for the spontaneous Hrhr mutation that exhibit a hair loss phenotype. However, it is time consuming 
to produce mice carrying both the reporter gene and mutant Hrhr gene by mating. In addition, there 
is a risk that genetic background of the gene-modified mice would be altered by mating. To resolve 
these issues, we established a simple method to generate hairless mice maintaining the original 
genetic background by CRISPR technology. First, we constructed the pX330 vector, which targets 
exon 3 of Hr. This DNA vector (5 ng/µl) was microinjected into the pronuclei of C57BL/6J mice. 
Induced Hr gene mutations were found in many founders (76.1%) and these mutations were heritable. 
Next, we performed in vivo imaging using these gene-modified hairless mice. As expected, luminescent 
objects in their body were detected by in vivo imaging. This study clearly showed that hairless mice 
could be simply generated by the CRISPR/Cas9 system, and this method may be useful for in vivo 
imaging studies with various gene-modified mice.
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Introduction
In vivo molecular imaging is an essential tool for de-
tecting target biomolecules directly and non-invasively, 
and for visualizing molecular processes. indocyanine 
green (ICG) is a common fluorescent molecule used in 
human medical diagnostics [15]. iCg is a cyanine dye 
that is removed exclusively by the liver and excreted 
into the bile [5]. iCg can be excited at 800 nm and emits 
fluorescence at 840 nm when bound with proteins [2]. 
Transient overexpression of near-infrared fluorescent 
protein (iRFP) causes bright fluorescence in cells, tis-
sues, and the entire animal body without the addition of 
exogenous biliverdin [7]. the irFP can be excited at 690 
nm and emits fluorescence at 713 nm. An optimal fluo-
rescent protein for in vivo imaging should have both 
excitation and emission maxima within a near-infrared 
window from ~650 nm to 900 nm, for which tissue has 
the lowest absorbance and less light scattering than at 
shorter wavelengths [12]. Therefore, iRFP is suitable for 
deep tissue imaging.
In vivo imaging with the iRFP makes it possible to 
(Received 1 May 2017 / Accepted 28 June 2017 / Published online in J-STAGE 18 July 2017)
Address corresponding: F. Sugiyama, Laboratory Animal Resource Center, University of Tsukuba, 1-1-1 Tennodai, Tsukuba, Ibaraki 305-8575, Japan
*These authors contributed equally to this study.
Supplementary Figures and Tables: refer to J-STAGE: https://www.jstage.jst.go.jp/browse/expanim
Exp. Anim. 66(4), 437–445, 2017
©2017 Japanese Association for Laboratory Animal Science
Y. HosHino, ET AL.438
detect fluorescent proteins in the living bodies of mice 
[14]. the hair blocks, absorbs, and scatters light. Espe-
cially, Black hair absorbs more light than other color 
hairs [22, 30]. As even white hair absorbs light, it is very 
difficult to detect fluorescence signals. Therefore, it is 
necessary to remove the hair from mice to detect the 
iRFP signal with in vivo imaging system. nude mice lack 
hair, although they are immunodeficient [8, 23]. The 
FoxN1 gene, located on chromosome 11, is responsible 
for these phenotypes [4, 21, 29]. Hr gene (refseq ac-
cession: NM_021877) mutants such as Hos:HR-1 mice 
also show hair loss without abnormalities in the immune 
system. these hairless mice are useful for not only skin, 
immunology, and cancer studies but also in vivo imaging 
[3, 9]. Gene-modified mice are often backcrossed to Hr 
mutant mice for in vivo imaging [20]. However, it is time 
consuming to produce mice carrying both a reporter gene 
for in vivo imaging and mutated Hr gene by mating. 
Moreover, if reporter gene is located on chromosome 14 
on which Hr gene is located, it is difficult to introduce 
both mutations by mating. in addition, there is the risk 
that the genetic background of the reporter mice would 
be changed by mating.
the CrisPr/Cas9 system is very convenient for in-
ducing specific mutations in various animals. This sys-
tem is composed of a single guide rna (sgrna) and 
Cas9 protein, which cause site-specific DNA double-
strand breaks (dsB), leading to indel mutations by non-
homologous end joining (NHEJ) [11, 25]. To shorten the 
time for producing hairless gene-modified mice and to 
eliminate the risk of changes in genetic background, we 
generated hairless mice for in vivo imaging using the 
CrisPr/Cas9 system.
In this study, we tried to produce new hairless mice 
using the CrisPr/Cas9 system for detecting irFP signal 
by in vivo imaging.
Materials and Methods
Animals
C57BL/6J and Jcl:CD1 (ICR) mice were purchased 
from Charles River Laboratories Japan (Kanagawa, Ja-
pan) and CLEA Japan (Tokyo, Japan), respectively. The 
iRFP transgenic mice were generated as described previ-
ously [30]. Hrhr/hr mice (RBRC01223) were provided by 
riKEn BrC through the national Bio-resource Project 
of the MEXT, Japan. Mice were kept in plastic cages 
under pathogen-free conditions in a room maintained at 
23.5 ± 2.5°C and 52.5 ± 12.5% relative humidity under 
a 14-h light:10-h dark cycle. Mice had free access to 
commercial chow (MF diet; Oriental Yeast, Tokyo, Ja-
pan) and filtered water. All mouse experiments were 
performed with the approval of the University of Tsu-
kuba animal Experiment Committee.
Vector construction
the pX330 plasmid, carrying both grna and Cas9 
expression units, was a gift from Dr. Feng Zhang (Ad-
dgene plasmid 42230) [6]. The oligos, Hr51 CRISPR F 
(5′-caccAGCCCCTGTGAACGGCATTG-3′) and Hr51 
CRISPR R (5′-aaacCAATGCCGTTCACAGGGGCT-3′), 
were annealed and inserted into the entry site of pX330 
as described previously [18]. The resulting plasmid was 
designated as pX330-Hr51. the oligos, p2color-Hr51 F 
(5′-aattAGCCCCTGTGAACGGCATTGTGG-3′) and 
p2color-Hr51 R (5′-ggccCCACAATGCCGTTCA-
CAGGGGCT-3′), were annealed and inserted into the 
entry site of p2color vector. This plasmid was desig-
nated as p2color-Hr51. Transfection into HEK293T cells 
and fluorescence observations were performed as de-
scribed previously [18].
Microinjection
Female C57BL/6J mice were injected with pregnant 
mare serum gonadotropin (PMsg) and human chori-
onic gonadotropin (hCG) with a 48-h interval, and 
mated with male C57BL/6J mice. The zygotes were col-
lected from the oviducts. then, the pX330-Hr51 dna 
vector (circular, 5 ng/µl) was injected into the pronuclei 
according to standard protocols [10]. the injected em-
bryos (pronuclei stage) were then transferred into pseu-
dopregnant iCr mice.
Genomic PCR and sequence analysis
Screening of founder mice (three weeks old) was per-
formed by PCr using genomic dna obtained from the 
tail. The PCR amplicons were passed through MCE-202 
MultiNA (Shimadzu, Kyoto, Japan), which is a micro-
chip electrophoresis system for DNA analysis. The off-
target effect was examined by PCR and direct sequenc-
ing [18]. PCR was performed with AmpliTaq Gold® 360 
Master Mix (applied Biosystems, Foster City, Ca) and 
the primers listed in supplementary table 1. the PCr 
products were purified with a Fast Gene Gel/PCR Extrac-
tion Kit, and sequences were analyzed using an Applied 
Biosystems 3130 Genetic Analyzer (Life Technologies, 
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Palo Alto, CA) with a BigDye® terminator v3.1 Cycle 
Sequencing Kit (Life Technologies).
Imaging of an ICG tube in hairless mice
The ICG tube was detected with an in vivo imaging 
system (IVIS Spectrum; PerkinElmer, Wellesley, MA) 
and a CT scanner (ALOKA La Theta LCT-100; Hitachi, 
Tokyo, Japan). All mice were anesthetized with isoflu-
rane. The ICG tube was inserted into the abdominal cav-
ity. Analysis of fluorescence signals was performed with 
Living Image Software 4.0 (Caliper LifeSciences, Hop-
kinton, Ma). three-dimensional (3d) reconstruction 
was performed with OsiriX Lite 7.5 (Pixmeo, Bernex, 
Switzerland).
Imaging of iRFP embryos
The iRFP fluorescence signal was detected with an in 
vivo imaging system (IVIS Spectrum). The iRFP-ex-
pressing embryos at 10.5 days post-coitum (dpc) in the 
uterus were assessed in female hairless mice crossed 
with iRFP-expressing male mice. All mice were anes-
thetized with isoflurane or sacrificed before imaging. 
The fluorescence signals were analyzed with Living Im-
age Software 4.3.1 (Caliper LifeSciences).
RNA extraction and cDNA synthesis
Total RNA from skin was extracted using Isogen (Nip-
pon Gene Co., Ltd., Tokyo, Japan) in accordance with 
the manufacturer’s instructions. cDNA was synthesized 
from 5 µg of rna using superscript ii reverse transcrip-
tase (Thermo Fisher Scientific, San Jose, CA) and oligo 
(dT) primer (Thermo Fisher Scientific). PCR was per-
formed with AmpliTaq Gold® 360 Master Mix (applied 
Biosystems) and the primers listed in supplementary 
Table 1. The PCR products were purified with a Fast 
Gene Gel/PCR Extraction Kit, and sequences were ana-
lyzed using an applied Biosystems 3130 genetic ana-
lyzer (Life Technologies) with a BigDye® terminator 
v3.1 Cycle Sequencing Kit (Life Technologies).
Blood sampling
The blood was sampled at the same time of day (10:00 
− 12:00) to control for the chronobiological variability 
of study parameters. Whole blood samples were taken 
with a 1-ml syringe and a 26-gauge needle from the 
caudal vena cava after laparotomy under anesthesia. For 
hematology analysis, the blood samples (0.1 ml) were 
placed in 1.5-ml tubes containing na2-Edta (dojindo 
Molecular technologies, Kumamoto, japan) and ana-
lyzed immediately. The remainder of each sample was 
collected in a 1.5-ml tube for blood chemistry, and the 
blood was allowed to clot for 30 min and centrifuged 
(3,000 × g, 5 min) for serum separation. serum samples 
were analyzed immediately [13].
Hematology
Hematology analyses were performed using Celltac α 
(MEK-6458; Nihon Kohden, Tokyo, Japan). The hema-
tological parameters investigated were white blood cell 
count (wBC), red blood cell count (rBC), hemoglobin 
concentration (HgB), hematocrit (HCt), mean corpus-
cular volume (MCV), mean corpuscular hemoglobin 
(MCH), mean corpuscular hemoglobin concentration 
(MCHC), and platelet count (PLT). The measurement 
method was same as previous report [30].
Blood chemistry
Blood chemistry parameters were measured using a 
Fuji dri-chem 7000 (Fuji-Film, tokyo, japan). the 
blood chemistry parameters investigated were aspartate 
aminotransferase, alanine aminotransferase, alkaline 
phosphatase, blood glucose, blood urea nitrogen, cre-
atinine, total protein, albumin, total bilirubin, calcium, 
inorganic phosphate, total cholesterol, triglyceride, so-
dium, potassium, and chloride. the measurement meth-
od was same as previous report [30].
Results
Generation of hairless mice by CRISPR/Cas9
to generate hairless mice by the CrisPr/Cas9 sys-
tem, we first targeted a sequence in the Hr gene. accord-
ing to UCSC Genome Browser, the Hr gene located on 
chromosome 14 has 20 exons. We targeted exon 3, which 
contains the start codon (Fig. 1). To decrease off-target 
candidates, we used the CRISPRdirect web server to 
design CrisPr/Cas guide rna [19]. the CrisPr tar-
get was located 51–73 bp downstream of the start codon 
of Hr. We inserted a 20-bp gRNA target into pX330, and 
the resultant plasmid was designated as pX330-Hr51. 
next, the cleavage activity of pX330-Hr51 was examined 
by the traffic reporter system [11]. The results indicated 
that pX330-Hr51 could efficiently cleave the target site 
(supplementary Fig. 1B).
we then microinjected 5 ng/µl of the pX330-Hr51 
dna vector (circular) into the pronuclei of 437 one-cell 
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stage embryos obtained from C57BL/6J mice. No mor-
phological abnormalities were observed in 395 of 437 
one-cell embryos immediately after microinjection. 
These one-cell embryos with a normal appearance were 
transferred into the oviducts of pseudopregnant recipient 
ICR mice, and 88 neonates, including six without hair, 
were obtained. The hairless phenotype caused by Hr 
mutation was inherited in a recessive manner. Therefore, 
we confirmed Hr gene mutation even in founders with 
hair. The heteroduplex mobility assay (HMA) with Mul-
tina revealed indel mutations in 67 of 88 mice, includ-
ing six with no hair (Table 1).
To determine whether the pX330-Hr51 dna vector 
was integrated into the chromosomes, we performed 
PCR with founder mouse genomic DNA and a primer 
pair for Cas9 detection. PCR products were detected in 
four founder mice (Table 1). Therefore, we succeeded 
in generating 63 (including five hairless) mutant mice 
without insertion of pX330. in the mice carried pX330-Hr 
chromosomal integration, ubiquitously expression of the 
grna for Hr and Cas9 may result in accumulating the 
off-target mutations in each somatic and germ cells. 
Therefore, we refrained from using them. In addition, 
off-targets of one male hairless founder were checked 
and no mutations were found (Supplementary Table 4).
Inheritance and gene expression
To confirm the hereditary and mutant sequence detail, 
male hairless founder #70 was crossed with a female 
wild-type mouse (Fig. 2A). we obtained 11 F1 mice with 
hair. Unexpectedly, three types of mutations were de-
tected in these animals: Δ2 (TT deletion), Δ5 (CGGCA 
deletion), and +1 (A insertion) (Fig. 2B). The mice car-
rying the same mutation sequence were intercrossed and 
all F2 homozygous mutants were hairless. As no different 
phenotypes were found among them, we used the Δ5 
hairless mouse line and their mutant allele was named 
Hrem1Utr.
we also investigated the Hr rna expression and its 
sequence from Hrem1Utr/em1Utr and Hrhr/hr mice. the 
Hrhr/hr mouse strain showed the hairless phenotype 
caused by spontaneous insertion mutation in intron 7 of 
the Hr gene, and has already been widely used in in vivo 
studies. the total rnas of homozygous mutant skin 
were collected and RT-PCR was performed with three 
primer pairs (exon 3 to exon 4, exon 7 to exon 12, and 
exon 13 to exon 19). PCR products were detected under 
all conditions (Figs. 3B–3d). We then confirmed the 
sequences of these rt-PCr products and detected the 
CrisPr-induced 5-bp deletion mutation in Hrem1Utr/
em1Utr mouse cDNA (Fig. 2B). The results indicated that 
the CrisPr-induced heritable genetic mutation resulted 
in mutant rna expression and hairless phenotype.
Hairless phenotype
We then confirmed that temporal changes in the hair-
less mouse phenotype in Hrem1Utr/em1Utr mice (Fig. 4 and 
Fig. 1. schematic for pX330-Hr51. the dna sequence indicate 
the CrisPr guide rna target site. the underlined letters 
indicate the protospacer adjacent motif (PaM) sequence. 
At the top of this figure, thin gray boxes indicate untrans-
lated regions. thick gray boxes indicate coding sequence 
regions.
Table 1. generation of CrisPr/Cas9-mediated Hr mutant mice
injected dna oocytes injected
oocytes  
transferred Number of newborns
Number of newborns  
without insertion of pX330
pX330-Hr51 (5 ng/μl) 437 395 Mutated and hairless   6 (6.8 %)a 5
Mutated 61 (69.3 %)b 58
wild-type 21 (23.9 %)c 21
sum 88 84 (95.5 %)d
aMutated and hairless/ Sum of newborns. bMutated newborns/ Sum of newborns. cWild-type newborns/ Sum of newborns. dNewborns 
without insertion of pX330/ Sum of newborns.
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Supplementary Fig. 2A) and Hrhr/hr mice (supplemen-
tary Figs. 2B and 2C). First, Hrem1Utr/em1Utr mice lost their 
ventral hair at 4 weeks of age. Next, the hair loss progres-
sive from the ventral side to the dorsal side in 2–4 weeks 
(Fig. 4 and Supplementary Fig. 2A). In contrast, the hair 
loss in Hrhr/hr mice started at 2 weeks of age [26]. It 
progressed rapidly from the rostral to the caudal side and 
Hrhr/hr mice were completely hairless by 4 weeks of age 
(Supplementary Figs. 2B and 2C) [28]. The Hrem1Utr/em1Utr 
mice grew slowly compared with wild-type controls 
(Supplementary Fig. 3). However, there was no differ-
ence in weight after 7 weeks of age. In hematology and 
blood chemistry analyses, we found minor differences 
related to red blood cells (Supplementary Table 2 and 
3). This phenotype was consistent with Hrhr/hr mice [24, 
27].
In vivo imaging of Hrem1Utr/em1Utr mice with ICG tube 
implantation
To confirm whether Hrem1Utr/em1Utr mice are available 
Fig. 2. Pedigree of founder #70 line. (a) Circles and squares represent female and male mice, 
respectively. The gray circles and squares represent hairless phenotypes. The small white, 
black, and gray circles indicate 2-bp deletion, 5-bp deletion, and 1-bp insertion alleles, 
respectively. (B) There were three types of mutation in the founder #70 line. The hyphens 
indicate deletion. The white letter indicates insertion.
Fig. 3. Reverse transcription PCR of wild-type, Hrem1Utr/em1Utr, and Hrhr/hr mice. (a) schematic for reverse tran-
scription PCR. The white arrow indicates the deletion region. The black arrows indicate primers. (B) The 
PCR products of 755 bp from exon 3 to exon 4, (C) 588 bp from exon 7 to exon 12, and (D) 760 bp from 
exon 13 to exon 19 are shown to demonstrate the presence of cDNA. WT, wild-type mice; Hrem1Utr, 
Hrem1Utr/em1Utr mice; Hrhr, Hrhr/hr mice.
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for in vivo imaging, ICG-filled artificial tubes were im-
planted into the abdominal cavity of Hrem1Utr/em1Utr mice. 
The tubes and fluorescence signals were detected by CT 
and IVIS, respectively. The position of the tube was 
consistent with that of ICG fluorescence (Figs. 5A–D). 
These results indicated that the ICG fluorescence could 
be easily detected in the abdominal cavity of 
Hrem1Utr/em1Utr mice.
To confirm whether Hrem1Utr/em1Utr mice are available 
for detecting vital irFP, female Hrem1Utr/em1Utr mice were 
Fig. 4. temporal changes in Hrem1Utr/em1Utr mice. Female Hrem1Utr/em1Utr mice lost ventral hair at 4 weeks of age. 
After 6 weeks of age, they gradually lost dorsal hair.
Fig. 5. In vivo imaging of Hrem1Utr/em1Utr mice with ICG tube implantation. (A) CT plane. The arrow 
indicates ICG tube. (B) IVIS plane. (C) Merge (CT + IVIS). (D) 3D reconstruction of merge 
by OsiriX Imaging Software. Orange light indicates fluorescence signal. Blue light indicates 
ICG tube. The ICG tube was easily identified using an IVIS Spectrum in vivo imaging 
system equipped with 745 nm excitation and 820 nm emission filters.
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crossed with iRFP-expressing male mice. The iRFP-
expressing embryos in the uterus were detected at 10.5 
dpc. The embryos with iRFP signals were detected in 
the coronal plane (Fig. 6a), the sagittal plane (Fig. 6B), 
and transverse plane (Fig. 6C). on 3d reconstruction of 
diffuse luminescence imaging tomography, three em-
bryos expressing iRFP were detected (Fig. 6D). After 
celiotomy, the positions of irFP-expressing embryos 
were almost consistent with those of iRFP fluorescence 
in 3D reconstruction (Fig. 6E). However, four rather than 
three embryos expressing iRFP were present in the 
uterus of the Hrem1Utr/em1Utr mouse (Fig. 6F). these re-
sults indicated that the irFP-expressing embryos could 
be detected in the uterus of Hrem1Utr/em1Utr mice.
Discussion
Using the CRISPR/Cas9 system, we generated a 
novel hairless mouse strain designated as Hrem1Utr/em1Utr 
mice. the complete hair loss in this mouse strain permit-
ted in vivo imaging with ICG and iRFP. Although minor 
abnormalities were found in red blood cells of this mouse 
strain in comparison with Hrhr mice [24, 27], there were 
no major abnormal phenotypes that prevented the normal 
biological activity and long-term in vivo imaging studies. 
these results indicated that the hairless mice generated 
by CRISPR/Cas9 were useful for in vivo imaging.
it is necessary to remove hair from mice before in vivo 
imaging, because hair blocks, absorbs, and scatters light. 
There are several ways to remove the hair without the 
need for genetic modification. Shaving with a razor can 
be performed easily to remove the hair, but is associated 
with a risk of scab formation due to bleeding, which also 
block, absorb, and scatter light. depilatory cream is also 
used, but this takes time. Especially, 3d in vivo imaging 
requires removal of hair from the whole body. In con-
trast, Hr mutant hairless mice make it possible to begin 
in vivo imaging immediately without removal of hair. 
This benefit becomes significant when many mice must 
be used or in vivo imaging must be repeated many times.
in general, female Hrhr/hr mice often fail to nurse their 
litters due to abnormal lactation. although outbred fe-
male Hrhr/hr mice, such as Hos:Hr-1 hairless mice, can 
nurse their litters, Hrhr/hr mice with the C57BL/6JJcl 
genetic background often fail to nurse their litters. in 
this study, female Hrem1Utr/em1Utr mice also failed to nurse 
their litters. therefore, our observations support the sug-
gestion that this low nursing activity is dependent on the 
genetic background [28].
Although the mechanism by which Hr mutations cause 
hair loss is not completely understood at the molecular 
level [16], several Hr mutant mouse stains have been 
reported. null Hr mice (Hr−/−), generated by gene target-
ing, showed both hair loss and severe wrinkling of the 
Fig. 6. In vivo imaging of Hrem1Utr/em1Utr mice crossed with iRFP transgenic mice. (A) Coronal plane. (B) Sagittal plane. (C) Trans-
verse plane. (D) 3D reconstruction of diffuse luminescence imaging tomography. (E), (F) Uterus after celiotomy. iRFP 
expression in embryos (10.5 dpc) was identified using an IVIS Spectrum in vivo imaging system equipped with 675 nm 
excitation and 720 nm emission filters.
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skin [31]. in this strain, the genomic region containing 
exons 7–11 of Hr was deleted and there was no expres-
sion of Hr mrna or Hr protein. the Hrrh-8j spontaneous 
mutant strain also showed both hair loss and wrinkling 
of the skin. this mutant carried a nonsense mutation of 
ga-to-tt substitution at positions 1,910 and 1,911 in 
exon 5 of Hr [1]. as Hrrh-8j mutant mrna may be de-
graded by nonsense-mediated mrna decay (nMd), 
small amounts of mutant mRNA were detected in their 
skin [31]. in contrast, Hrhr/hr mice did not show wrinkling 
of the skin but did show hair loss. The Hrhr allele has a 
spontaneous retroviral insertion (approximately 13 kb) 
into intron 7 [28]. Both wild-type Hr mRNA and two 
additional long mRNAs were expressed from this allele 
[31]. these additional long mrnas may arise from ab-
errant splicing and act in a dominant negative manner to 
cause the observed loss of hair. these previous reports 
suggested that Hr null mutation yields both hair loss and 
severe wrinkling of the skin. Conversely, partial inhibi-
tion of Hr leads to hair loss but not to wrinkling of the 
skin. interestingly, Hrhr/hr mice showed complete hair 
loss and very mild wrinkling of the skin. In addition, 
mutant Hrem1Utr mRNA was not degraded (Figs. 3B–3D). 
The CRISPR target sequence was designed according to 
exon 3 of Hr and a 5-bp deletion was induced within its 
target site. this deletion may induce a frameshift muta-
tion with a stop codon in exon 3 (Supplementary Fig. 
4a). in theory, this mutant mrna should be degraded 
by NMD. However, there was no difference in the ex-
pression level of this mRNA between wild-type and 
Hrem1Utr/em1Utr mice (Fig. 3). these data suggest that an 
in-frame atg, other than the original start codon, func-
tions as an illegitimate start codon and an n-terminal 
truncated Hr protein results in the phenotype with hair 
loss and very mild wrinkling of the skin (Supplemen-
tary Figs. 4a  and 4B). thus, such as truncated protein 
which was induced by indel mutation was reported from 
another group [17]. on the other hands, there is also a 
possibility that this phenotypic difference is depended 
on genetic background because those of Hrhr/hr and 
Hrem1Utr/em1Utr mice are C57BL/6JJcl and C57BL/6J, 
respectively.
Although three iRFP-expressing embryos were iden-
tified in 3D reconstruction of diffuse luminescence imag-
ing tomography (Fig. 6d), four irFP-expressing em-
bryos were identified in the uterus after celiotomy (Fig. 
6F). In fact, our results indicated that it is difficult to 
distinguish adjacent irFP-expressing embryos (10.5 
dpc). in late pregnancy, it may be possible to distinguish 
adjacent irFP-expressing embryos. Further studies are 
required to establish the method for analyzing the em-
bryos in utero from implantation to perinatal stage.
In conclusion, we generated a novel hairless mouse 
strain, Hrem1Utr/em1Utr, using CrisPr/Cas9. these hair-
less mice enabled the in vivo imaging with ICG tubes 
and irFP transgenic mice. the CrisPr/Cas9 system 
could be useful for generating genetically modified hair-
less mice for in vivo imaging studies.
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